Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-21-020099

← back to feed
Filed
Aug 16, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jun 30, 2021 42.96M sh
Cash And Equivalents Q2 2021 · Jun 30, 2021 $40.73K
Cash And Equivalents Q2 2021 · Dec 31, 2020 $118.61K
Total Liabilities Q2 2021 · Jun 30, 2021 $13.87K
Total Liabilities Q2 2021 · Dec 31, 2020 $14.76K
Total Assets Q2 2021 · Jun 30, 2021 $40.73K
Total Assets Q2 2021 · Dec 31, 2020 $118.61K
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$74.41K
Stockholders Equity Q2 2021 · Jun 30, 2020 $151.14K
Stockholders Equity Q2 2021 · Dec 31, 2019 $234.91K
Sga Expense Q2 2021 · Jun 30, 2020 $53.66K
Sga Expense Q2 2021 · Jun 30, 2020 $98.8K
Net Income Q2 2021 · Jun 30, 2020 −$53.65K
Net Income Q2 2021 · Jun 30, 2020 −$83.78K
Operating Income Q2 2021 · Jun 30, 2020 −$53.66K
Operating Income Q2 2021 · Jun 30, 2020 −$83.8K
Revenue Q2 2021 · Jun 30, 2020 $15K